Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
113,311,223
-
Share change
-
+6,513,390
-
Total reported value
-
$326,351,131
-
Put/Call ratio
-
109%
-
Price per share
-
$2.88
-
Number of holders
-
146
-
Value change
-
+$12,893,347
-
Number of buys
-
88
-
Number of sells
-
44
Institutional Holders of ACHILLION PHARMACEUTICALS IN - COM (ACHN) as of Q4 2017
As of 31 Dec 2017,
ACHILLION PHARMACEUTICALS IN - COM (ACHN) was held by
146 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
113,311,223 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, BlackRock Inc., Vanguard Group Inc, ORBIMED ADVISORS LLC, STATE STREET CORP, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, GOLDMAN SACHS GROUP INC, BAKER BROS. ADVISORS LP, and DEUTSCHE BANK AG\.
This page lists
146
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.